Vertiv Q3 EPS Tops by $0.25, Revenue Climbs 29%, Raises FY2025 Guidance
Vertiv reported Q3 EPS of $1.24, beating estimates by $0.25, and revenue of $2.68B, 29% higher YoY, surpassing consensus by $0.09B. It issued Q4 2025 EPS guidance of $1.230–1.290 and FY2025 guidance of $4.070–4.130, while raising its quarterly dividend from $0.04 to $0.0625.
1. Barclays Upgrade Sparks Double-Digit Jump
Vertiv shares climbed more than 8% on Friday after a prominent Barclays analyst raised the firm’s price target to $200. The stock gapped sharply higher at the open on heavy volume, a signal of significant institutional participation. Trading activity was nearly double the 30-day average, suggesting buy-side conviction behind the move. The upgrade cited accelerating demand in hyperscale data centers and resilience in telecom infrastructure spending as key catalysts.
2. Generali Asset Management Increases Position
In its latest SEC filing, Generali Asset Management SPA SGR disclosed a 37.8% increase in its Vertiv stake during the third quarter, adding 3,874 shares to bring its total holding to 14,130 shares. At the end of the period, the stake was valued at approximately $2.13 million. The move underscores confidence from a top European asset manager and pushes institutional ownership of Vertiv to nearly 90% of the float.
3. Third-Quarter Results and Upward Guidance
Vertiv reported Q3 revenue of $2.68 billion, beating consensus by $90 million and reflecting year-over-year growth of 29%. Adjusted EPS came in at $1.24, topping estimates by $0.25, while net margin expanded to 10.7%. The company reaffirmed its Q4 EPS outlook of $1.23–$1.29 and raised full-year guidance to $4.07–$4.13, underscoring confidence in robust backlog conversion and ongoing strength in power and thermal management segments.
4. Dividend Hike, Insider Sale and Analyst Sentiment
Vertiv boosted its quarterly dividend by over 50% to $0.0625 per share, representing a 0.1% yield and a payout ratio under 10%. On the insider front, EVP Stephen Liang sold 5,501 shares, reducing his stake by 57.6% in late November. Analyst coverage remains favorable: of 29 respondents, two rate the stock a Strong Buy, 21 rate Buy, five rate Hold and one Sell, with an average target above current levels and recent upward revisions from Morgan Stanley, Oppenheimer and Evercore ISI.